Michael Okun

Freethink filmmakers highlight people and ideas changing the world, and their latest focus is UF’s multidisciplinary DBS team.

In The Conversation, Dr. Michael Okun explains Parkinson’s disease and evolving treatments for the condition.

Read about how the MBI and Fixel institutes are working together to propel neuroscience and neuromedicine research at UF.

A new article in the journal Neurology by a University of Zurich medical team examines the negative effect deep brain stimulation surgery had on the swimming skills of a select group of patients with Parkinson’s disease. University of Florida neurology chair Dr. Michael Okun commented on the study in The New York Times and urges all patients with Parkinson’s disease to avoid swimming alone.

In the journal JAMA Neurology, Dr. Michael Okun discusses the challenge of selecting an appropriate DBS system for an individual patient.

JAMA Neurology's rankings were determined by a quantitative measure of the attention each scholarly article received in traditional and social media.

In a recent editorial in JAMA Neurology, a group of neurologists at at The Fixel Center for Neurological Diseases at UF Health discuss medication trends for Parkinson's disease dementia.

The Institute for Human and Machine Cognition's podcast, STEM-Talk, features Michael Okun, M.D., who talks about the complexity and treatment of Parkinson's disease.

DBS pioneers Kelly Foote, M.D., and Michael Okun, M.D., co-directors of the Fixel Center for Neurological Diseases at UF Health, shared their expertise at the Cade Museum.

MBI members discuss how the service and science hub specialty care model is working at the Fixel Center.